new Alzheimer's drug, Exelon (rivastigmine, Novartis)

May 2000

You're going to start hearing about the new Alzheimer's drug, Exelon (rivastigmine, Novartis). ...

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

NSAIDs contribute to congestive heart failure in elderly patients
Infectious Diseases penicillin TWICE DAILY for Strep throat
Infectious Diseases Zyvox (linezolid), a potent new antibiotic for gram-positive infections
Osteoporosis Actonel (risedronate) is now approved for osteoporosis
Women s Health whether hormone replacement therapy really reduces the risk of heart disease
Cardiology thrombotic thrombocytopenic purpura (TTP) with Plavix (clopidogrel)
new dietary recommendations for antioxidants
Men s Health Uprima (you-PREE-ma), a new prescription alternative to Viagra
Neurology Pain new Alzheimer's drug, Exelon (rivastigmine, Novartis)
Neurology Pain new seizure drug, Zonegran (zonisamide)
Gastroenterology alternative to Propulsid for heartburn and other GI disorders
Gastroenterology new drug for treating severe dry mouth, Evoxac (EE-vo-zak, cevimeline)
many drugs remain safe and effective long after their expiration date
Diabetes Lantus, a new long-acting BASAL insulin
Supplements vitamin C to help PREVENT the rare nerve disorder that occurs after an injury or fracture